Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial
文献类型:期刊论文
作者 | Li, Ning1; Zhang, Youzhong2; Wang, Jing3; Zhu, Jianqing4; Wang, Li5; Wu, Xiaohua6; Yao, Desheng7; Wu, Qiang8; Liu, Jihong9; Tang, Junying10 |
刊名 | GYNECOLOGIC ONCOLOGY
![]() |
出版日期 | 2021-08-01 |
卷号 | 162 |
ISSN号 | 0090-8258 |
WOS研究方向 | Oncology ; Obstetrics & Gynecology |
语种 | 英语 |
WOS记录号 | WOS:000687070800098 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/125046] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 2.Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China 3.Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China 4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Beijing, Peoples R China 5.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China 6.Fudan Univ, Affiliated Canc Hosp, Shanghai, Peoples R China 7.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China 8.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China 9.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 10.Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Ning,Zhang, Youzhong,Wang, Jing,et al. Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial[J]. GYNECOLOGIC ONCOLOGY,2021,162. |
APA | Li, Ning.,Zhang, Youzhong.,Wang, Jing.,Zhu, Jianqing.,Wang, Li.,...&Wu, Lingying.(2021).Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial.GYNECOLOGIC ONCOLOGY,162. |
MLA | Li, Ning,et al."Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial".GYNECOLOGIC ONCOLOGY 162(2021). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。